Progress on the Beam Energy Monitor for the SPIRAL2 Accelerator.

WEPF29, posterInternational audienceThe first part of the SPIRAL2 project entered last year in the end of the construction phase at GANIL in France. The facility will be composed by an ion source, a deuteron/proton source, a RFQ and a superconducting linear accelerator. The driver is planned to accelerate high intensities, up to 5 mA and 40 MeV for the deuteron beams. A monitoring system was built to measure the beam energy on the BTI line (Bench of Intermediate Test) at the exit of the RFQ. As part of theMEBT commissioning, the beamenergy will be measured on the BTI with an Epics monitoring application. At the exit of the LINAC, another system will have to measure and control the beam energy. The control consists in ensuring that the beam energy stays under a limit by taking account of the measurement uncertainty. The energy is measured by a method of time of flight; the signal is captured by non-intercepting capacitive pick-ups. This paper describes the BTI monitor interface and presents the system evolution following the design review

Supervision of the ATLAS High Level Trigger System

Talk from the 2003 Computing in High Energy and Nuclear Physics (CHEP03), La Jolla, Ca, USA, March 2003, 6 pages, PDF (from MS Word). PSN TUGT009; Available at http://www.slac.stanford.edu/econf/C0303241/proc/papers/TUGT009.PDF pers/THJT006.PDFInternational audienceThe ATLAS High Level Trigger (HLT) system provides software-based event selection after the initial LVL1 hardware trigger. It is composed of two stages, the LVL2 trigger and the Event Filter. The HLT is implemented as software tasks running on large processor farms. An essential part of the HLT is the supervision system, which is responsible for configuring, coordinating, controlling and monitoring the many hundreds of processes running in the HLT. A prototype implementation of the supervision system, using tools from the ATLAS Online Software system is presented. Results from scalability tests are also presented where the supervision system was shown to be capable of controlling over 1000 HLT processes running on 230 nodes

The y activity from 11Li beta decay

The energies and absolute intensities of the γ-rays from the β-decay of 11Li are measured. There is no sizable β branch to the 11Be ground state. Only (5.2 ± 1.4) % of the β-decay strength does not lead to β-delayed particle emission. New β-delayed neutron branches to excited states of 10Be are observed and the total delayed neutron emission probability is deduced

Subconjunctival Injection of XG-102, a c-Jun N-Terminal Kinase Inhibitor Peptide, in the Treatment of Endotoxin-Induced Uveitis in Rats.

Abstract Purpose: XG-102, a TAT-coupled dextrogyre peptide inhibiting the c-Jun N-terminal kinase, was shown efficient in the treatment of experimental uveitis. Preclinical studies are now performed to determine optimal XG-102 dose and route of administration in endotoxin-induced uveitis (EIU) in rats with the purpose of clinical study design. METHODS: EIU was induced in Lewis rats by lipopolysaccharides (LPS) injection. XG-102 was administered at the time of LPS challenge by intravenous (IV; 3.2, 35 or 355 μg/injection), intravitreal (IVT; 0.08, 0.2 or 2.2 μg/eye), or subconjunctival (SCJ; 0.2, 1.8 or 22 μg/eye) routes. Controls received either the vehicle (saline) or dexamethasone phosphate injections. Efficacy was assessed by clinical scoring, infiltrating cells count, and expression of inflammatory mediators [inducible nitric oxide synthase (iNOS), cytokine-induced neutrophil chemoattractant-1 (CINC-1)]. The effect of XG-102 on phosphorylation of c-Jun was evaluated by Western blot. RESULTS: XG-102 demonstrated a dose-dependent anti-inflammatory effect in EIU after IV and SCJ administrations. Respective doses of 35 and 1.8 μg were efficient as compared with the vehicle-injected controls, but only the highest doses, respectively 355 and 22 μg, were as efficient as dexamethasone phosphate. After IVT injections, the anti-inflammatory effect of XG-102 was clinically evaluated similar to the corticoid's effect with all the tested doses. Regardless of the administration route, the lowest efficient doses of XG-102 significantly decreased the ration of phospho c-Jun/total c-Jun, reduced cells infiltration in the treated eyes, and significantly downregulated iNOS and CINC-1 expression in the retina. CONCLUSION: These results confirm that XG-102 peptide has potential for treating intraocular inflammation. SCJ injection appears as a good compromise to provide a therapeutic effect while limiting side effects

Preliminary implementation for the new SPIRAL2 project control system

International audienceThe Spiral2 project consists of a new facility to provide high intensity rare ions beams. It is based on a primary beam driver accelerator (RFQ followed by a superconducting linac) and a rare ion production process delivering the beam either to a low energy experimental area or to the existing Ganil facility. From October this year, one ion source coupled with a first beam line section will be in test; then, the injector (ion and deuteron sources, RFQ) will be tested by the end of 2010 so the whole accelerator should be commissioned by the end of 2011; the first exotic beams being planned one year later. The accelerator control system design results from the collaboration between several institutes and Epics has been chosen as the basic framework. The paper therefore presents the main choices: MVME5500 CPUs, VME I/O boards, VxWorks, Siemens PLCs, Modbus field buses, EDM screens and Java applications, Linux PCs, use of a LabView/Epics gateway... Specific topics are the evaluation of the XAL environment, an Epics design to address the power supplies, an emittance measurement system, the development of a beam profiler interface and the investigation for a triggered acquisition system

Propofol requirement and EEG alpha band power during general anesthesia provide complementary views on preoperative cognitive decline

Background: Although cognitive decline (CD) is associated with increased post-operative morbidity and mortality, routinely screening patients remains difficult. The main objective of this prospective study is to use the EEG response to a Propofol-based general anesthesia (GA) to reveal CD. Methods: 42 patients with collected EEG and Propofol target concentration infusion (TCI) during GA had a preoperative cognitive assessment using MoCA. We evaluated the performance of three variables to detect CD (MoCA < 25 points): age, Propofol requirement to induce unconsciousness (TCI at SEF95: 8–13 Hz) and the frontal alpha band power (AP at SEF95: 8–13 Hz). Results: The 17 patients (40%) with CD were significantly older (p < 0.001), had lower TCI (p < 0.001), and AP (p < 0.001). We found using logistic models that TCI and AP were the best set of variables associated with CD (AUC: 0.89) and performed better than age (p < 0.05). Propofol TCI had a greater impact on CD probability compared to AP, although both were complementary in detecting CD. Conclusion: TCI and AP contribute additively to reveal patient with preoperative cognitive decline. Further research on post-operative cognitive trajectory are necessary to confirm the interest of intra operative variables in addition or as a substitute to cognitive evaluation

Surface modification of flax yarns by enzymatic treatment and their interfacial adhesion with thermoset matrices

The aim of this study was to assess the effects of commercially available and relatively inexpensive enzyme preparations based on endo 1,4-β-xylanase, pectinase and xyloglucanase on the thermal (TGA), morphological (SEM), chemical (FT-IR) and mechanical (single yarn tensile tests) properties of flax yarns. The preparation based on pectinase and xyloglucanase provided the best results, resulting in the effective removal of hydrophilic components such as hemicellulose and pectin, the individualization of yarns and increased thermal stability at the expense of a reduction in mechanical properties, depending on the treatment parameters. Single yarn fragmentation tests pointed out an improved interfacial adhesion after enzymatic treatment, with reduced debonding length values of 18% for an epoxy matrix and up to 36% for a vinylester resin compared to untreated flax yarns

A novel inhibitor of p75-neurotrophin receptor improves functional outcomes in two models of traumatic brain injury.

The p75 neurotrophin receptor is important in multiple physiological actions including neuronal survival and neurite outgrowth during development, and after central nervous system injury. We have discovered a novel piperazine-derived compound, EVT901, which interferes with p75 neurotrophin receptor oligomerization through direct interaction with the first cysteine-rich domain of the extracellular region. Using ligand binding assays with cysteine-rich domains-fused p75 neurotrophin receptor, we confirmed that EVT901 interferes with oligomerization of full-length p75 neurotrophin receptor in a dose-dependent manner. Here we report that EVT901 reduces binding of pro-nerve growth factor to p75 neurotrophin receptor, blocks pro-nerve growth factor induced apoptosis in cells expressing p75 neurotrophin receptor, and enhances neurite outgrowth in vitro Furthermore, we demonstrate that EVT901 abrogates p75 neurotrophin receptor signalling by other ligands, such as prion peptide and amyloid-β. To test the efficacy of EVT901 in vivo, we evaluated the outcome in two models of traumatic brain injury. We generated controlled cortical impacts in adult rats. Using unbiased stereological analysis, we found that EVT901 delivered intravenously daily for 1 week after injury, reduced lesion size, protected cortical neurons and oligodendrocytes, and had a positive effect on neurological function. After lateral fluid percussion injury in adult rats, oral treatment with EVT901 reduced neuronal death in the hippocampus and thalamus, reduced long-term cognitive deficits, and reduced the occurrence of post-traumatic seizure activity. Together, these studies provide a new reagent for altering p75 neurotrophin receptor actions after injury and suggest that EVT901 may be useful in treatment of central nervous system trauma and other neurological disorders where p75 neurotrophin receptor signalling is affected

First step towards the new SPIRAL2 project control system

International audienceThe Spiral2 project at Ganil aims to produce rare ion beams using a Uranium carbide target fission process. The accelerator consists of a RFQ followed by a superconducting cavity linac and is designed to provide high intensity primary beams (deuterons, protons or heavy ions). The accelerator should be commissioned by the end of 2011; then, the first tests aiming to produce exotic beams are planned one year later. The control system will result of the collaboration between several institutes among which the Saclay Dapnia division yet having a good experience and knowledge with Epics. So and also because of its widely used functionalities, Epics has been chosen as the basic framework for the accelerator control and people from the other laboratories belonging to the collaboration are progressively acquiring a first experience with Epics. The paper first explains the organisation of the collaboration then it describes the basic hardware and software choices for the project. Some preliminary implementations are therefore given. As the project is still in its beginning phase, the paper ends by listing some interrogations not yet solved for the control system definition and opened for discussion

The mediating role of innovation in the relationship between market orientation and university performance in Pakistan

Universities globally are going through a paradigm shift with a need to become more innovatively market-oriented to handle the issue of growing competition for funding, as well as attracting/retaining the international/local competent students and academicians. However, there appears to be a dearth of research on how such state of affairs could be addressed, particularly in the emerging economies like Pakistan. In the light of resource-based theory (RBT), as well as organizational-learning theory (OLT), literature suggests that market-orientation (MO) and innovation are to be the desirable unique resources, as well as the guiding philosophies, to enable universities for a more competitive performance. Hence, this study investigated how resources like marketorientation (MO), and innovation, can influence university performance (UP). The study also tested empirically the potential mediating effect of innovation on the MOUP relationship. In addition, how the dimensions of MO influenced the innovation and university performance (UP) were also tested empirically in the universities of Pakistan. Results of the PLS path modelling (with 369 respondents from the target public-sector universities) firstly confirmed significant effect of the “universal construct of MO” and two of its dimensions “the advising and mentoring, as well as the intelligencegeneration and response” on UP. However, one dimension of MO, which is the administration-leadership, was not significantly supported to directly influence the UP. Secondly, the study confirmed that there were significant direct effects of the “universal construct of MO”, as well as all of its dimensions, on innovation. Thirdly, the study also found that there was a significant effect of innovation on UP. Furthermore, the bootstrapping results found significant mediation of innovation between the MO-UP relationship. Hence, the results show that UP can be directly enhanced through MO and innovation. Even the use of innovation as a mediator can further strengthen the MO-UP relationship. Based on the findings, the study offers theoretical and practical implications, followed by its limitations and directions, for future research